Impact of postprogression therapies on overall survival: Recommendations from the 2023 kidney cancer association think ...
Modern advances in systemic and localized therapies for patients with renal cell carcinoma (RCC) have significantly improved patients' outcomes. If disease progression occurs after initial treatment, clinicians often have multiple options for a first …